Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02B VITAMIN K AND OTHER HEMOSTATICS
B02BX Other systemic hemostatics
B02BX09 Fostamatinib
D09348 Fostamatinib disodium (USAN) <JP/US>
USP drug classification [BR:br08302]
Blood Products and Modifiers
Platelet Modifying Agents
Platelet Modifying Agents, Other
Fostamatinib
D09348 Fostamatinib disodium (USAN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D09348 Fostamatinib disodium (USAN); Fostamatinib sodium hydrate (JAN)
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01419 Fostamatinib
D09348 Fostamatinib disodium
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG01419 Fostamatinib
D09348 Fostamatinib disodium
Metabolizing enzyme inhibitor
DG02852 CYP3A/CYP3A4 inhibitor
DG01419 Fostamatinib
D09348 Fostamatinib disodium
Transporter inhibitor
DG01622 ABCB1 inhibitor
DG01419 Fostamatinib
D09348 Fostamatinib disodium
DG02862 ABCG2 inhibitor
DG01419 Fostamatinib
D09348 Fostamatinib disodium
Target-based classification of drugs [BR:br08310]
Protein kinases
Non-receptor tyrosine kinases
SYK family
SYK
D09348 Fostamatinib disodium (USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09348
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09348
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09348
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09348
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09348
Drug transporters
D09348
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01419 Fostamatinib
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG01419 Fostamatinib
Metabolizing enzyme inhibitor
DG02852 CYP3A/CYP3A4 inhibitor
DG01419 Fostamatinib
Transporter inhibitor
DG01622 ABCB1 inhibitor
DG01419 Fostamatinib
DG02862 ABCG2 inhibitor
DG01419 Fostamatinib